Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody Injection, covering 2026-01-28 to 2026-01-28. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody Injection [Phase 1]